Clinical trial
Long-term Follow-up of Patients With Alcoholic Liver Cirrhosis Who Had Administered Cellgram-LC in PMC-P-07 Study
NCT05093881 is registered in ClinicalTrials.gov with Pharmicell Co., Ltd. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Long-term Follow-up of Patients With Alcoholic Liver Cirrhosis Who Had Administered Cellgram-LC in PMC-P-07 Study
- Lead sponsor
- Pharmicell Co., Ltd.
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- September 9, 2021
- Completion date
- December 31, 2031
- Enrollment
- 100 (estimated)
- Sites
- 14
Conditions
As the registry lists them; a condition with its own page is linked.
alcoholic liver cirrhosis